Related Experiment Video
Updated: Jun 19, 2026

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
Published on: April 24, 2016
Management of Oral Mucositis in Pediatric Patients: A Practical Overview of Available Treatment
Carly Mulinda1, Neha Kinariwalla2, Amy R DeFelice3
1Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
Abstract:
Oral mucositis (OM) is an inflammatory condition associated with breakdown of the protective mucosal barrier. Clinically, it can range from mucosal erythema to painful ulcerations that can lead to malnutrition, secondary infection, and increased medical costs due to hospitalizations. Existing literature regarding OM primarily investigates antineoplastic-induced OM in the adult population; however, many non-oncologic disease processes can present with OM, including autoimmune and infectious conditions such as pemphigus vulgaris, recurrent aphthous stomatitis, oral lichen planus, and reactive infectious mucocutaneous eruption. Management of OM is largely palliative and can be grouped into four domains: pain control, oral decontamination, nutritional support, and palliation of dry mouth. This review aims to articulate the current topical management strategies for symptom relief and treatment of OM in children secondary to non-oncologic disease processes. Future studies are needed to strengthen the evidence base for interventions in children with refractory OM that is not caused by oncotherapy.
More Related Videos
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Tonsillitis II: Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

